Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
MDxHealth SA MDXH.BR
$0.35
-$0.01 (-2.49%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
97877919.00000000
-
week52high
0.97
-
week52low
0.26
-
Revenue
37054000
-
P/E TTM
-1
-
Beta
0.83893100
-
EPS
-0.24000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 14:00
Описание компании
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии